Inventor · disambiguated record
Howard B. Cottam
Also filed as: COTTAM HOWARD · COTTAM HOWARD B
31 granted patents·24 pending applications·910 citations·filing 1987–2023
97Inventor score
Top patents by PatentIndex Score
55 records- 0197US6562819B2Compounds for inhibition of ceramide-mediated signal transductionUNIV CALIFORNIA·Filed 2001·Granted May 13, 2003·106 cites·14 claims
- 0296US9050376B2Conjugates of synthetic TLR agonists and uses thereforUNIV CALIFORNIA·Filed 2014·Granted Jun 9, 2015·47 cites·11 claims
- 0395US6323201B1Compounds for inhibition of ceramide-mediated signal transductionUNIV CALIFORNIA·Filed 1997·Granted Nov 27, 2001·138 cites·18 claims
- 0494US8729088B2Toll-like receptor modulators and treatment of diseasesCARSON DENNIS A·Filed 2010·Granted May 20, 2014·63 cites·18 claims
- 0593US5801193ACompositions and methods for immunosuppressingIMMUNE MODULATION INC·Filed 1997·Granted Sep 1, 1998·93 cites·4 claims
- 0693US5041426AImmune system enhancing 3-β-d-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and nucleotidesUNIV BRIGHAM YOUNG·Filed 1988·Granted Aug 20, 1991·70 cites·23 claims
- 0792US8790655B2Conjugates of synthetic TLR agonists and uses thereforUNIV CALIFORNIA·Filed 2013·Granted Jul 29, 2014·18 cites·12 claims
- 0890US4880784AAntiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivativesUNIV BRIGHAM YOUNG·Filed 1987·Granted Nov 14, 1989·99 cites·17 claims
- 0989US9505768B2Compositions and methods for modulating TLR4UNIV CALIFORNIA·Filed 2015·Granted Nov 29, 2016·12 cites·14 claims
- 1087US8846697B2Purine analogsCARSON DENNIS A·Filed 2007·Granted Sep 30, 2014·13 cites·13 claims
- 1187US7361680B2Indole compounds useful for the treatment of cancerUNIV CALIFORNIA·Filed 2006·Granted Apr 22, 2008·12 cites·5 claims
- 1286US7151100B1Indole compounds useful for the treatment of cancerUNIV CALIFORNIA·Filed 2000·Granted Dec 19, 2006·17 cites·13 claims
- 1385US7601846B2Compounds having activity as inhibitors of apoptosisUNIV CALIFORNIA·Filed 2005·Granted Oct 13, 2009·7 cites·4 claims
- 1485US7129262B2Indole compounds useful for the treatment of cancerUNIV CALIFORNIA·Filed 2004·Granted Oct 31, 2006·15 cites·11 claims
- 1583US7189752B2Use of etodolac for the treatment of chronic lymphocytic leukemiaCARSON DENNIS A·Filed 2004·Granted Mar 13, 2007·14 cites·14 claims
- 1683US6696441B1Inhibition of p53-induced stress responseUNIV CALIFORNIA·Filed 2000·Granted Feb 24, 2004·13 cites·9 claims
- 1782US6545034B1Use of etodolac for the treatment of chronic lymphocytic leukemiaUNIV CALIFORNIA·Filed 1999·Granted Apr 8, 2003·52 cites·5 claims
- 1881US7105561B2Use of etodolac for the treatment of prostate cancerUNIV CALIFORNIA·Filed 2002·Granted Sep 12, 2006·17 cites·8 claims
- 1978US9359360B2TLR agonistsGRIMSHAW SUZANNE·Filed 2012·Granted Jun 7, 2016·6 cites·13 claims
- 2075US7105560B1Use of etodolac in the treatment of multiple myelomaUNIV CALIFORNIA·Filed 2000·Granted Sep 12, 2006·14 cites·12 claims
- 2174US5843943ACompounds for inhibition of ceramide-mediated signal transductionUNIV CALIFORNIA·Filed 1995·Granted Dec 1, 1998·42 cites·9 claims
- 2268US6162810AInadone and tetralone compounds for inhibiting cell proliferationUNIV CALIFORNIA·Filed 1998·Granted Dec 19, 2000·13 cites·42 claims
- 2364US2007111950A1Indole compounds useful for the treatment of cancerCARSON DENNIS A·Filed 2006·Application pending·0 cites
- 2461US2025281465A1Molecules that enhance extracellular vesicle releaseCARSON DENNIS A·Filed 2023·Application pending·0 cites
- 2559US5840505AMethod for inhibiting adenylosuccinate synthetase activity in methylthioadenosine phosphorylase deficient cellsUNIV CALIFORNIA·Filed 1996·Granted Nov 24, 1998·11 cites·13 claims
- 2659US2005154010A1Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogsUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 2756US2003216426A1Treatment of cancer with mefloquine, its purified enantiomers, and mefloquine analogsUNIV CALIFORNIA·Filed 2002·Application pending·0 cites
- 2854US7229979B2Hypoestoxides, derivatives and agonists thereof for use as stent-coating agentsIMMUNE MODULATION INC·Filed 2004·Granted Jun 12, 2007·0 cites·13 claims
- 2954US5747474AImmunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosidesIMMUNE MODULATION INC·Filed 1996·Granted May 5, 1998·10 cites·6 claims
- 3054US2016199499A1Uses of phospholipid conjugates of synthetic tlr7 agonistsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 3154US2005004144A1Combined use of IMPDH inhibitors with toll-like receptor agonistsUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 3254US2015132342A1Novel immune activators: substitute 4-aminoquinazolinesUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 3354US2013190494A1Purine analogsOF CALIFORNIA THE REGENTS OF THE UNIVERSITY·Filed 2013·Application pending·0 cites
- 3454US2006040934A1Use of STAT-6 inhibitors as therapeutic agentsUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 3554US2023365570A1Compounds with glucocorticoid sparing effects and uses thereofUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3652US2009324551A1Tlr agonistsUNIV CALIFORNIA·Filed 2006·Application pending·0 cites
- 3751US6214571B1Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cellsUNIV CALIFORNIA·Filed 1998·Granted Apr 10, 2001·8 cites·11 claims
- 3851US2022305121A1N-aryl sulfonamide derivatives as vaccine adjuvantUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 3950US7098216B2Thiazolopyrimidines useful as TNFα inhibitorsUNIV CALIFORNIA·Filed 2004·Granted Aug 29, 2006·0 cites·12 claims
- 4049US2004127435A1Uses for inhibitors of inosine monophosphate dehydrogenaseUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 4149US2011306671A1Amide derivatives of ethacrynic acidCARSON DENNIS A·Filed 2009·Application pending·0 cites
- 4248US2003232794A1Use of STAT-6 inhibitors as therapeutic agentsFiled 2003·Application pending·0 cites
- 4347US2003143199A1Use of STAT-6 inhibitors as therapeutic agentsFiled 2002·Application pending·0 cites
- 4447US2004087553A1Hypoestoxides, derivatives and agonists thereof for use in the treatment and prophylaxis of hyperlipidemiaPARAQUEST INC·Filed 2003·Application pending·0 cites
- 4546US10857122B2Hypoestoxide, derivatives, related compounds, and agonists thereof for treatment or prevention of neurodegenerative diseasesIMMUNE MODULATION INC·Filed 2016·Granted Dec 8, 2020·0 cites·6 claims
- 4645US2004152672A1Indole compounds useful for the treatment of cancerFiled 2003·Application pending·0 cites
- 4744US8124654B2Derivatives of hypoestoxide and related compoundsCOTTAM HOWARD B·Filed 2008·Granted Feb 28, 2012·0 cites·19 claims
- 4844US2022152188A1Tlr4-tlr7 ligand formulations as vaccine adjuvantsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 4944US2021380546A1Vaccine adjuvantUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 5041US7816352B2Apoptosis inhibitorsUNIV CALIFORNIA·Filed 2006·Granted Oct 19, 2010·0 cites·30 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Howard B. Cottam files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →